⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

June 25, 2026Circulation JournalOpen Access

Myocardial Perfusion and Fluorodeoxyglucose Uptake Patterns in Cardiac Sarcoidosis Stratified by Diagnostic Category and Systemic Involvement

Daniel Sykora Jen Davison Gregorio Tersalvi Mohamed Elwazir Omar AbouEzzeddine John Bois John Giudicessi Panithaya Chareonthaitawee Leslie Cooper A. Rosenbaum

View Full Paper

Ask AI

Bookmark

Share

Key Points

To characterize 18F-FDG PET/CT patterns in cardiac sarcoidosis among different diagnostic subgroups.
Utilized 18F-FDG PET/CT imaging to analyze myocardial perfusion and glucose uptake in cardiac sarcoidosis.
Categorized participants based on diagnostic subgroups and systemic involvement.
Identified distinct FDG uptake patterns related to the diagnostic categories.
Noted differences in myocardial perfusion correlating with systemic involvement in cardiac sarcoidosis.

Implication

Examines myocardial perfusion and FDG uptake in cardiac sarcoidosis, suggesting patterns by diagnostic category.

Abstract

Background: 18F-FDG PET/CT patterns in cardiac sarcoidosis (CS) across diagnostic subgroups are incompletely characterized.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Sykora et al. (2026) studied this question.

synapsesocial.com/papers/6a40b92b61bb0a67205c58ea https://doi.org/10.1253/circj.cj-26-0423

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

118F-fluorodeoxyglucose PET computed tomography in cardiac sarcoidosis: lessons from a 10-year reviewCohort Study · 2026 · 1 citations
2C66-02 Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography as a Prognostic Tool for Cardiac SarcoidosisCohort Study · 2026
3Utility of FDG PET and Cardiac MRI in Diagnosis and Monitoring of Immunosuppressive Treatment in Cardiac Sarcoidosiscohort · 2020 · 42 citations
4Cardiac Positron Emission Tomography Enhances Prognostic Assessments of Patients With Suspected Cardiac Sarcoidosiscohort · 2013 · 710 citations
5The role of FDG-PET/CT in assessing cardiac sarcoidosis with no high-risk cardiac features and normal CMRcohort · 2025 · 3 citations

More related papers

FDG PET-CT uncovers cardiac sarcoidosis when CMR is inconclusive: the impact of multimodal imaging2026
Combined simultaneous FDG-PET/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis2021
Intense 68Ga-OncoFAP Uptake as a New Promising Diagnostic Biomarker in Cardiac Sarcoidosis2024

More from Circulation Journal

Bayesian Real-Time Decision Support for Strategy Optimization in Chronic Total Occlusion Percutaneous Coronary InterventionTue,
Determinants and Clinical Impact of Direct Stenting in Optical Coherence Tomography-Guided Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction ― An ATLAS-OCT Substudy ―Tue,